9 Meters Biopharma (NMTR)

NMTR was delisted on the 25th of July, 2023.

• Market cap: $1.04M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: 9 Meters Biopharma Inc is a clinical-stage biopharmaceutical company focused on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. Its products include NM-002, Larazotide, NM-003, and others.

Employees: 10